Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
While there is consistent evidence for increased presynaptic dopamine synthesis capacity in the striatum of patients with schizophrenia during psychosis, it is unclear whether this also holds for patients during psychotic remission. This study investigates whether striatal dopamine synthesis capacity is altered in patients with schizophrenia during symptomatic remission of positive symptoms, and whether potential alterations relate to symptoms other than positive, such as cognitive difficulties. Twenty-three patients with schizophrenia in symptomatic remission of positive symptoms according to Andreasen, and 24 healthy controls underwent 18F-DOPA-PET and behavioural-cognitive assessment. Imaging data were analysed with voxel-wise Patlak modelling with cerebellum as reference region, resulting in the influx constant kicer reflecting dopamine synthesis capacity. For the whole striatum and its subdivisions (i.e. limbic, associative, and sensorimotor), averaged regional kicer values were calculated, compared across groups, and correlated with behavioural-cognitive scores, including a mediation analysis. Patients had negative symptoms (Positive and Negative Syndrome Scale-negative 14.13 ± 5.91) and cognitive difficulties, i.e. they performed worse than controls in Trail-Making-Test-B (TMT-B; P = 0.01). Furthermore, kicer was reduced in patients for whole striatum (P = 0.004) and associative (P = 0.002) and sensorimotor subdivisions (P = 0.007). In patients, whole striatum kicer was negatively correlated with TMT-B (rho = -0.42, P = 0.04; i.e. the lower striatal kicer, the worse the cognitive performance). Mediation analysis showed that striatal kicer mediated the group difference in TMT-B. Results demonstrate that patients with schizophrenia in symptomatic remission of positive symptoms have decreased striatal dopamine synthesis capacity, which mediates the disorder's impact on cognitive difficulties. Data suggest that striatal dopamine dysfunction contributes to cognitive difficulties in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The reward circuit: linking primate anatomy and human imaging
Haber, S. N., & Knutson, B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.129 · Cited by 3,718
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Trail Making Test A and B: normative data stratified by age and education
Tombaugh, T. (2004) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(03)00039-8 · Cited by 3,239
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Hayes, A. F., & Rockwood, N. J. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.11.001 · Cited by 2,350
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
Parent, A., & Hazrati, L.-N. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00007-c · Cited by 2,161
Keefe, R. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.011 · Cited by 1,573
The primate basal ganglia: Parallel and integrative networks
Haber, S. N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.003 · Cited by 1,479
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
Research works printed but not linked: 69
- Abi-Dargham, 1998, Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort, Am J Psychiatry, 155, 761
- Alexander, 1986, Parallel organization of functionally segregated circuits linking basal ganglia and cortex, Ann Rev Neurosci, 9, 357, 10.1146/annurev.ne.09.030186.002041 · DOI · Paper page
- Allen, 2008, Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database, Nat Genet, 40, 827, 10.1038/ng.171 · DOI · Paper page
- Andreasen, 2005, Remission in schizophrenia: proposed criteria and rationale for consensus, Am J Psychiatry, 162, 441, 10.1176/appi.ajp.162.3.441 · DOI · Paper page
- Arbuthnott, 2000, Executive control in set switching: residual switch cost and task-set inhibition, Can J Exp Psychol, 54, 33, 10.1037/h0087328 · DOI · Paper page
- Ashok, 2017, The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment, Mol Psychiatry, 22, 666, 10.1038/mp.2017.16 · DOI · Paper page
- Avram, 2018, Cortico-thalamic hypo- and hyperconnectivity extend consistently to basal ganglia in schizophrenia, Neuropsychopharmacology, 43, 2239, 10.1038/s41386-018-0059-z · DOI
- Beaulieu, 2004, Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade, Proc Natl Acad Sci USA, 101, 5099, 10.1073/pnas.0307921101 · DOI · Paper page
- Benarroch, 2016, Intrinsic circuits of the striatum: complexity and clinical correlations, Neurology, 86, 1531, 10.1212/WNL.0000000000002599 · DOI · Paper page
- Berggren, 1985, The effect of acute lithium administration on brain monoamine synthesis and the precursor amino acids tyrosine and tryptophan in brain and plasma in rats, J Neural Transm, 61, 175, 10.1007/BF01251911 · DOI
- Berry, 2016, Aging affects dopaminergic neural mechanisms of cognitive flexibility, J Neurosci, 36, 12559, 10.1523/JNEUROSCI.0626-16.2016 · DOI · Paper page
- Berry, 2018, The influence of dopamine on cognitive flexibility is mediated by functional connectivity in young but not older adults, J Cogn Neurosci, 30, 1330, 10.1162/jocn_a_01286 · DOI
- Bloomfield, 2014, Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms, Biol Psychiatry, 75, 470, 10.1016/j.biopsych.2013.05.027 · DOI · Paper page
- Bongiovanni, 2008, Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels, Brain Res, 1190, 39, 10.1016/j.brainres.2007.10.079 · DOI
- Carlsson, 1978, Antipsychotic drugs, neurotransmitters, and schizophrenia, Am J Psychiatry, 135, 165, 10.1176/ajp.135.2.164 · DOI · Paper page
- Chen, 2006, Trait vs. state markers for schizophrenia: identification and characterization through visual processes, Curr Psychiatry Rev, 2, 431, 10.2174/157340006778699729 · DOI · Paper page
- Cirillo, 2003, Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms, Neuropsychol Rev, 13, 43, 10.1023/A:1023870821631 · DOI · Paper page
- Cropley, 2008, Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [C-11]NNC 112 and [F-18]FDOPA, Psychiat Res-Neuroim, 163, 171, 10.1016/j.pscychresns.2007.11.003 · DOI
- Cumming, 1998, Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms, Synapse, 29, 37, 10.1002/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO;2-C · DOI · Paper page
- Cumming, 1993, Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans, J Cereb Blood Flow Metab, 13, 668, 10.1038/jcbfm.1993.85 · DOI · Paper page
- D’Souza, 2012, Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits, Neuropharmacology, 62, 1564, 10.1016/j.neuropharm.2011.01.044 · DOI · Paper page
- Demjaha, 2012, Dopamine synthesis capacity in patients with treatment-resistant schizophrenia, Am J Psychiatry, 169, 1203, 10.1176/appi.ajp.2012.12010144 · DOI · Paper page
- Diedrichsen, 2009, A probabilistic MR atlas of the human cerebellum, Neuroimage, 46, 39, 10.1016/j.neuroimage.2009.01.045 · DOI · Paper page
- Edwards, 2016, Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study, Schizophr Res, 176, 136, 10.1016/j.schres.2016.06.016 · DOI · Paper page
- Egerton, 2010, The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function, Neuroimage, 50, 524, 10.1016/j.neuroimage.2009.12.058 · DOI · Paper page
- Elkashef, 2000, 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography, Psychiatry Res, 100, 1, 10.1016/S0925-4927(00)00064-0 · DOI
- First, 2002, Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition (SCID-I/P)
- Frankle, 2006, Prefrontal cortical projections to the midbrain in primates: evidence for a sparse connection, Neuropsychopharmacology, 31, 1627, 10.1038/sj.npp.1300990 · DOI
- Fusar-Poli, 2013, Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies, Schizophr Bull, 39, 33, 10.1093/schbul/sbr180 · DOI · Paper page
- Gardner, 2010, International consensus study of antipsychotic dosing, Am J Psychiatry, 167, 686, 10.1176/appi.ajp.2009.09060802 · DOI · Paper page
- Grunder, 2003, Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo, Neuropsychopharmacology, 28, 787, 10.1038/sj.npp.1300103 · DOI
- Hartvig, 1991, Brain kinetics of L-[beta-11C]dopa in humans studied by positron emission tomography, J Neural Transm Gen Sect, 86, 25, 10.1007/BF01250373 · DOI
- Hayes, 2013, Introduction to mediation, moderation, and conditional process analysis: a regression-based approach
- Hietala, 1999, Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia, Schizophr Res, 35, 41, 10.1016/S0920-9964(98)00113-3 · DOI · Paper page
- Hietala, 1995, Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients, Lancet, 346, 1130, 10.1016/S0140-6736(95)91801-9 · DOI · Paper page
- Hoffman, 1992, The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography, J Nucl Med, 33, 1472
- Howes, 2012, The nature of dopamine dysfunction in schizophrenia and what this means for treatment, Arch Gen Psychiatry, 69, 776, 10.1001/archgenpsychiatry.2012.169 · DOI · Paper page
- Howes, 2014, Schizophrenia: an integrated sociodevelopmental-cognitive model, Lancet, 383, 1677, 10.1016/S0140-6736(13)62036-X · DOI · Paper page
- Karrer, 2017, Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: a meta-analysis, Neurobiol Aging, 57, 36, 10.1016/j.neurobiolaging.2017.05.006 · DOI · Paper page
- Kay, 1987, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophr Bull, 13, 261, 10.1093/schbul/13.2.261 · DOI · Paper page
- Keefe, 2007, Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial, Arch Gen Psychiatry, 64, 633, 10.1001/archpsyc.64.6.633 · DOI · Paper page
- Kienast, 2013, Dopamine-modulated aversive emotion processing fails in alcohol-dependent patients, Pharmacopsychiatry, 46, 130, 10.1055/s-0032-1331747 · DOI
- Kim, 2017, Presynaptic dopamine capacity in patients with treatment-resistant schizophrenia taking clozapine: an [(18)F]DOPA PET study, Neuropsychopharmacology, 42, 941, 10.1038/npp.2016.258 · DOI
- Kumakura, 2009, PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches, Neuroscientist, 15, 635, 10.1177/1073858409338217 · DOI · Paper page
- Laruelle, 1999, Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies, J Psychopharmacol, 13, 358, 10.1177/026988119901300405 · DOI · Paper page
- Lindstrom, 1999, Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET, Biol Psychiatry, 46, 681, 10.1016/S0006-3223(99)00109-2 · DOI · Paper page
- Mair, 2002, A double dissociation within striatum between serial reaction time and radial maze delayed nonmatching performance in rats, J Neurosci, 22, 6756, 10.1523/JNEUROSCI.22-15-06756.2002 · DOI · Paper page
- Malhi, 2013, Potential mechanisms of action of lithium in bipolar disorder. Current understanding, CNS Drugs, 27, 135, 10.1007/s40263-013-0039-0 · DOI · Paper page
- McCutcheon, 2018, Defining the locus of dopaminergic dysfunction in schizophrenia: a meta-analysis and test of the mesolimbic hypothesis, Schizophr Bull, 44, 1301, 10.1093/schbul/sbx180 · DOI · Paper page
- McFarlane, 2011, Acute lithium administration selectively lowers tyrosine levels in serum and brain, Brain Res, 1420, 29, 10.1016/j.brainres.2011.08.054 · DOI
- McGowan, 2004, Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study, Arch Gen Psychiatry, 61, 134, 10.1001/archpsyc.61.2.134 · DOI · Paper page
- Mundt, 1989, The diagnostic specificity of negative symptoms and their psychopathological context, Br J Psychiatry Suppl, 32, 10.1192/S0007125000291447 · doi:10.1192/s0007125000291447
- Nozaki, 2009, Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET, Schizophr Res, 108, 78, 10.1016/j.schres.2008.11.006 · DOI · Paper page
- Okochi, 2009, Meta-analysis of association between genetic variants in COMT and schizophrenia: an update, Schizophr Res, 110, 140, 10.1016/j.schres.2009.02.019 · DOI
- Oram, 2005, Executive control of working memory in schizophrenia, Psychiatry Res, 135, 81, 10.1016/j.psychres.2005.03.002 · DOI
- Patlak, 1985, Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations, J Cereb Blood Flow Metab, 5, 584, 10.1038/jcbfm.1985.87 · DOI · Paper page
- Patlak, 1983, Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data, J Cerebr Blood F Met, 3, 1, 10.1038/jcbfm.1983.1 · DOI · Paper page
- Pogarell, 2012, Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms, Pharmacopsychiatry, 45, S36, 10.1055/s-0032-1306313 · DOI · Paper page
- Reichenberg, 2010, The assessment of neuropsychological functioning in schizophrenia, Dialogues Clin Neurosci, 12, 383, 10.31887/DCNS.2010.12.3/areichenberg · DOI · Paper page
- Salthouse, 2011, What cognitive abilities are involved in trail-making performance?, Intelligence, 39, 222, 10.1016/j.intell.2011.03.001 · DOI · Paper page
- Schabram, 2014, Acute and sustained effects of methylphenidate on cognition and presynaptic dopamine metabolism: an [18F]FDOPA PET study, J Neurosci, 34, 14769, 10.1523/JNEUROSCI.1560-14.2014 · DOI
- Sesack, 2002, Synaptology of dopamine neurons, 10.1007/978-3-642-56051-4_4 · DOI
- Shotbolt, 2011, Striatal dopamine synthesis capacity in twins discordant for schizophrenia, Psychol Med, 41, 2331, 10.1017/S0033291711000341 · DOI · Paper page
- Thompson, 2013, Striatal dopamine release in schizophrenia comorbid with substance dependence, Mol Psychiatry, 18, 909, 10.1038/mp.2012.109 · DOI · Paper page
- Tunbridge, 2006, Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond, Biol Psychiatry, 60, 141, 10.1016/j.biopsych.2005.10.024 · DOI · Paper page
- van Rossum, 1966, The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs, Arch Int Pharmacodyn Ther, 160, 492
- Vernaleken, 2007, ‘Prefrontal’ cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation, Hum Brain Mapp, 28, 931, 10.1002/hbm.20325 · DOI · Paper page
- Weinstein, 2017, Pathway-Specific Dopamine Abnormalities in Schizophrenia, Biol Psychiatry, 81, 31, 10.1016/j.biopsych.2016.03.2104 · DOI · Paper page
- Wils, 2017, Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis, Schizophr Res, 182, 42, 10.1016/j.schres.2016.10.030 · DOI
Cited by
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612
Negative symptoms, striatal dopamine and model-free reward decision-making in schizophrenia
Brandl, F., Knolle, F., Avram, M., Leucht, C., Yakushev, I., Priller, J., Leucht, S., Ziegler, S., Wunderlich, K., & Sorg, C. (2023) · Brain · doi:10.1093/brain/awac268 · Cited by 24
Self-citationMagnetic resonance imaging of the dopamine system in schizophrenia – A scoping review
Schulz, J., Zimmermann, J., Sorg, C., Menegaux, A., & Brandl, F. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.925476 · Cited by 14
Self-citation
Metadata
- Authors
- Avram, M., Brandl, F., Cabello, J., Leucht, C., Scherr, M., Mustafa, M., Leucht, S., Ziegler, S., & Sorg, C.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-04-26
- Volume
- 142
- Issue
- 6
- Pages
- 1813-1826
- ISSN
- 0006-8950
- 1460-2156
- Cited by
- 70
- References
- 32
- Language
- en
- Funders
- European Union 7th Framework Programme
- TRIMAGE (602621)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.